
Sydney-based Macquarie Group Ltd. has agreed to acquire approximately a 40% minority stake in Portuguese hospital operator Luz Saude SA from Fidelidade-Companhia de Seguros SA, a subsidiary of Fosun International Ltd. This strategic deal, which outbid rivals CVC Capital Partners and KKR & Co., implies an enterprise valuation exceeding €1 billion for Luz Saude, signaling Macquarie's expansion into the European healthcare sector.
Macquarie Group Ltd. is set to acquire a significant minority stake of approximately 40% in Portuguese hospital operator Luz Saude SA from Fidelidade-Companhia de Seguros SA, which is controlled by Fosun International Ltd. This transaction values Luz Saude at an enterprise value exceeding €1 billion, establishing a strong valuation benchmark for European healthcare assets. The deal is particularly noteworthy as Macquarie prevailed in a competitive bidding process, outmaneuvering private equity firms CVC Capital Partners Plc and KKR & Co., which underscores the high investor appetite for this sector. The moderately positive sentiment score of 0.6 reflects market approval of this strategic expansion by Macquarie into European healthcare, while the negative sentiment for KKR (-0.4) logically corresponds to its unsuccessful bid for the asset.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.60
Ticker Sentiment